Member Info for Laura2022

Https://www.bbc.co.uk/news/science-environment-66847977

Great news

Another £15k Tricky ?

Buying now at a pace

Minni and RB seem to have a strange pattern of posts on VAL and PYC

They will not allow you to buy at 1.7p

Amazing to see Brighty

Very strange post Righback given your comments on the 12th

6 shares bought

How can that be?

In the continued fight against cancer

Yesterday and all last week it seemed the maximum buy was dropped to only 150,000 -200,000 shares

Why are they showing 1.8p to sell when it's 1.9p in reality ?

It will move when the buys v sells changes

Most shares have periods of time (sometimes hours) where there is no visible change

That would be tremendous

Hopefully more to come

Good morning Rily

Thanks,yes I have just read your Feb thoughts ,I will await full results and see how things have improved as per trading statement

And yes, I have been purchasing shares over the last 3 weeks in FCS

A very nice Summary Acker

Thanks

L

Thankyou Kidlington

Daily Mail article August 2023

GlaxoSmithKline has begun using AI to make its medical treatments more personalised for individual patients

These recruitment efforts are often the longest part of the drug development process, but GSK said that using AI has allowed it to analyse massive quantities of data, making some parts of the clinical trial procedure up to five times faster.

AI has also been found to be useful for increasing the chances of a new medicine being successful in treating patients

From PYC website regarding PYC A.I applications

Personalised Dosing Tool Development

Data Identification

Identified public domain data on treatment of prostate cancer using docetaxel for 400+ patients from the comparator arm of a clinical tria

AI & Machine Learning

Applied AI techniques such as neural networks and other machine learning approaches to identify key factors linking dose, toxicity and efficacy

Web-Based Tool

Developed a web-based tool that could, if approved, form the basis of a decision support system for clinicians treating patients with prostate cancer to help reduce cost of toxicity and improve outcomes for patients

Just gone through